Key facts
- This page summarizes Tilak Mandadi's Form 4 filing for CVS HEALTH Corp (CVS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 May 2026, 17:27.
Tilak Mandadi - 08 May 2026 Form 4 Insider Report for CVS HEALTH Corp (CVS)
- Reporting relationship
- EVP, Chief Exp & Tech Officer
- Issuer ticker
- CVS
- Reported as of
- 08 May 2026
- Net transaction value
- -$6,230,379
- SEC form
- 4
- Accepted by SEC
- 11 May 2026, 17:27:40 UTC
- Prior SEC filing
- 02 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tilak Mandadi
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Tilak Mandadi filed Form 4 for CVS HEALTH Corp (CVS) on 11 May 2026.
Change
- Previous filing in this sequence was filed on 02 Apr 2026.
- Current net transaction value: -$6,230,379.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001872827
Primary reporting owner
Mandadi Tilak
- Relationship
- EVP, Chief Exp & Tech Officer
- Address
- ONE CVS DRIVE, WOONSOCKET
- Signature
- /s/ Tilak Mandadi
- Signature date
- 11 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVS
transaction
Common Stock
Sale
- Transaction value
- $6,230,379
- Shares
- -69,551
- Change %
- -87%
- Price
- $89.58
- Shares after
- 10,133
- Date
- 08 May 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
All shares sold at an Average price between $89.30 and $89.81.